Cardiol Therapeutics Inc (CRDL)
1.80
-0.04
(-2.17%)
USD |
NASDAQ |
Apr 26, 11:15
Cardiol Therapeutics Net Income (TTM): -20.82M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -20.82M |
September 30, 2023 | -20.75M |
June 30, 2023 | -22.43M |
March 31, 2023 | -21.96M |
December 31, 2022 | -23.78M |
September 30, 2022 | -23.21M |
June 30, 2022 | -24.98M |
March 31, 2022 | -25.24M |
December 31, 2021 | -25.20M |
September 30, 2021 | -27.66M |
June 30, 2021 | -23.09M |
March 31, 2021 | -20.36M |
Date | Value |
---|---|
December 31, 2020 | -15.53M |
September 30, 2020 | -10.43M |
June 30, 2020 | -9.774M |
March 31, 2020 | -9.881M |
December 31, 2019 | -10.31M |
September 30, 2019 | -14.85M |
June 30, 2019 | -15.96M |
March 31, 2019 | -14.29M |
December 31, 2018 | -12.11M |
September 30, 2018 | -5.708M |
June 30, 2018 | -2.379M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-27.66M
Minimum
Sep 2021
-9.774M
Maximum
Jun 2020
-19.28M
Average
-20.82M
Median
Dec 2023
Net Income (TTM) Benchmarks
Aurinia Pharmaceuticals Inc | -78.02M |
Acasti Pharma Inc | -38.77M |
Edesa Biotech Inc | -7.718M |
Lexaria Bioscience Corp | -5.440M |
Xenon Pharmaceuticals Inc | -182.39M |